ArticleDiabetology & metabolic syndrome2014

CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models.

Manoj Kumar Sadasivuni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.